FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Sun Pharmaceutical Industries Gabapentin Capsules Recall

Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Apr 16, 2025
Recall ID
D-0312-2025
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Gabapentin Capsules starting Mar 4, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0312-2025 on Apr 16, 2025. Reason: Cross Contamination. Status: Ongoing.

Why it was recalled

Cross Contamination

Product description

Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.

Lot numbers, UPCs & expiration codes

Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0312-2025
Classification
Class III
Status
Ongoing
Recall initiated
Mar 4, 2025
FDA report date
Apr 16, 2025
Quantity
852 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0312-2025, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
96415
Address
2 Independence Way
Code information
Lot # a) HAD1712B, Exp. date 03/2025 b) HAD1712C, exp. date 03/2025
Postal code
08540-6620
Report date
Apr 16, 2025
Product type
Drugs
Recall number
D-0312-2025
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
852 bottles
Reason for recall
Cross Contamination
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 4, 2025
Initial firm notification
Letter
Center classification date
Apr 4, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0312-2025, published Apr 16, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls